These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
660 related articles for article (PubMed ID: 9583862)
1. Indefinite survival of skin allografts in adult thymectomized, antilymphocyte serum-treated mice given bone marrow and thymus grafts of donor origin: tolerance induction by donor bone marrow and thymus. Fukuzaki T; Hancock WW; Monaco AP; Maki T Transplantation; 1998 Apr; 65(8):1036-43. PubMed ID: 9583862 [TBL] [Abstract][Full Text] [Related]
2. Determination of an improved sirolimus (rapamycin)-based regimen for induction of allograft tolerance in mice treated with antilymphocyte serum and donor-specific bone marrow. Hale DA; Gottschalk R; Maki T; Monaco AP Transplantation; 1998 Feb; 65(4):473-9. PubMed ID: 9500619 [TBL] [Abstract][Full Text] [Related]
3. Induction of tolerance to skin allografts by intrathymic injection of donor splenocytes. Effect of donor-recipient strain combination and supplemental rapamycin. Dono K; Maki T; Wood ML; Monaco AP Transplantation; 1995 Dec; 60(11):1268-73. PubMed ID: 8525521 [TBL] [Abstract][Full Text] [Related]
4. Allograft and xenograft unresponsiveness induced by transplantation of neonatal skin. Jamshidi F; De Fazio SR; Gozzo JJ Transplantation; 1993 Jul; 56(1):135-8. PubMed ID: 8333035 [TBL] [Abstract][Full Text] [Related]
5. Superiority of sirolimus (rapamycin) over cyclosporine in augmenting allograft and xenograft survival in mice treated with antilymphocyte serum and donor-specific bone marrow. Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP Transplantation; 1997 Feb; 63(3):359-64. PubMed ID: 9039923 [TBL] [Abstract][Full Text] [Related]
6. Active role of chimerism in transplantation tolerance induced by antilymphocyte serum, sirolimus, and bone-marrow-cell infusion. Kanamoto A; Monaco AP; Maki T Transplantation; 2004 Sep; 78(6):825-30. PubMed ID: 15385800 [TBL] [Abstract][Full Text] [Related]
7. Induction of specific unresponsiveness (tolerance) to skin allografts by intrathymic donor-specific splenocyte injection in antilymphocyte serum-treated mice. Ohzato H; Monaco AP Transplantation; 1992 Dec; 54(6):1090-5. PubMed ID: 1465774 [TBL] [Abstract][Full Text] [Related]
8. Late adjunctive therapy with single doses of rapamycin in skin-allografted mice treated with antilymphocyte serum and donor bone marrow cells. De Fazio SR; Plowey JM; Hartner WC; Gozzo JJ Transpl Immunol; 1996 Jun; 4(2):105-12. PubMed ID: 8843586 [TBL] [Abstract][Full Text] [Related]
9. Immunologic mechanisms in tolerance produced in mice with nonradiation-based lymphoablation and donor-specific bone marrow. Hale DA; Gottschalk R; Umemura A; Maki T; Monaco AP Transplantation; 2002 Aug; 74(4):477-84. PubMed ID: 12352905 [TBL] [Abstract][Full Text] [Related]
10. Donor T cells are not required for induction of allograft tolerance in mice treated with antilymphocyte serum, rapamycin, and donor bone marrow cells. Umemura A; Monaco AP; Maki T Transplantation; 2000 Oct; 70(7):1005-9. PubMed ID: 11045634 [TBL] [Abstract][Full Text] [Related]
11. Induction of donor-specific unresponsiveness to rat cardiac allografts by pretreatment with intrathymic donor MHC class I antigens. Oluwole SF; Chowdhury NC; Fawwaz RA Transplantation; 1993 Jun; 55(6):1396-402. PubMed ID: 8516825 [TBL] [Abstract][Full Text] [Related]
12. Donor-specific tolerance by perioperative intrathymic injection of bone marrow cells in the rat cardiac allograft model: use of FK506 can shorten the necessary duration of pretransplant intrathymic conditioning. Ito A; Ito T; Kamiike W; Moriguchi A; Ohkawa A; Uchikoshi F; Tanaka S; Nakata S; Matsuda H Transplantation; 1997 Sep; 64(5):752-7. PubMed ID: 9311715 [TBL] [Abstract][Full Text] [Related]
13. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide. Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492 [TBL] [Abstract][Full Text] [Related]
14. Host thymectomy and cyclosporine lead to unstable skin graft tolerance after class I mismatched allogeneic neonatal thymic transplantation in mice. RodrÃguez-Barbosa JI; Haller GW; Zhao G; Sachs DH; Sykes M Transpl Immunol; 2005 Oct; 15(1):25-33. PubMed ID: 16223670 [TBL] [Abstract][Full Text] [Related]
15. Mixed allogeneic reconstitution (A+B----A) to induce donor-specific transplantation tolerance. Permanent acceptance of a simultaneous donor skin graft. Ildstad ST; Wren SM; Oh E; Hronakes ML Transplantation; 1991 Jun; 51(6):1262-7. PubMed ID: 1828637 [TBL] [Abstract][Full Text] [Related]
16. Suppressor cells in specific unresponsiveness to skin allografts in ALS-treated, marrow-injected mice. Wood ML; Monaco AP Transplantation; 1980 Mar; 29(3):196-200. PubMed ID: 6444769 [TBL] [Abstract][Full Text] [Related]
17. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation. Tomita Y; Sachs DH; Khan A; Sykes M Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363 [TBL] [Abstract][Full Text] [Related]
18. Induction of tolerance to hind limb allografts in rats receiving cyclosporine A and antilymphocyte serum: effect of duration of the treatment. Ozer K; Oke R; Gurunluoglu R; Zielinski M; Izycki D; Prajapati R; Siemionow M Transplantation; 2003 Jan; 75(1):31-6. PubMed ID: 12544867 [TBL] [Abstract][Full Text] [Related]